Compound class

Cognitive and sleep peptides

Neuropeptides, a sleep peptide and a few oral compounds.

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.

Semax is a synthetic heptapeptide analog of the ACTH 4-10 fragment,1 selank is a synthetic analog of the endogenous tuftsin molecule,2 and DSIP (emideltide) is a synthetic nonapeptide.3 FDA's 2026 briefing found no pharmacokinetic study of semax in humans, proposed not adding semax to the 503A bulks list for compounding, and raised concerns about immunogenicity and a possible risk of bleeding.1 Other members are oral drugs, such as armodafinil, which its US label calls a wakefulness-promoting agent.4

Compounds in this class 16

Half-lives side by side

The figure each source gives, on one scale. Bars are ranges.

  • Oxytocinabout 1 to 6 min
  • DSIP (Delta Sleep-Inducing Peptide)8 min
  • Methylene Blueabout 24 h, IV

Log scale, 1 minute to about 3 weeks. Each figure and its source are in the list above. Minutes, days and weeks are turned into hours (1 day is 24 hours) only to place them on the scale. These are the sources' figures; the half-life the app uses to draw levels can differ.

Guides 10

Calculators 1

Compare 1

Logged in Milligram

Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.

  • Semax3%

Semax, how often

  • Daily60%
  • Every other day33%
  • Twice a week3%
  • Weekly3%
  • Less often0%

How often: among people with three or more logged doses, by the average gap between their doses.

Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.

References 7

  1. US Food and Drug Administration. Evaluation of Semax-related bulk drug substances (Semax (free base) and Semax acetate) for inclusion on the 503A bulk drug substances list. FDA briefing document, Pharmacy Compounding Advisory Committee, July 23-24, 2026 (dated 5/11/2026). 2026. fda.gov
  2. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. 2016. PMC4757669
  3. U.S. Food and Drug Administration. FDA presentation on emideltide-related bulk drug substances, Pharmacy Compounding Advisory Committee, 24 July 2026. 2026. fda.gov
  4. Cephalon, LLC. Nuvigil (armodafinil) label, version 32. 2022. DailyMed label
  5. U.S. Food and Drug Administration. FDA Evaluation of Emideltide-Related Bulk Drug Substances (Emideltide (free base) and Emideltide acetate). Briefing document for the Pharmacy Compounding Advisory Committee meeting of 23-24 July 2026, dated 11 May 2026. FDA evaluation
  6. American Regent, Inc. ProvayBlue (methylene blue) injection. US prescribing information, DailyMed record version 28, 2025. DailyMed label
  7. Par Health USA, LLC. Pitocin (oxytocin injection, USP) prescribing information. DailyMed 2026. DailyMed label

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.